SPECC1L

Cytospin-A · Q69YQ0 · SPECC1L on Sugi Atlas →

0 patent compounds predicted against SPECC1L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SPECC1L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations EARLY_PHASE1COMPLETED
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results nanCOMPLETED
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC) nanRECRUITING
Esophageal Squamous Cell Cancer Surveillance With Cytosponge nanCOMPLETED
Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer nanWITHDRAWN
Influence of the Surgical Technique Used for Colectomies on the Concentration of Circulating Tumor DNA and the Presence of Circulating Tumor Cells: Comparison of the no Touch Technic With Either First Clamping of the Mesenteric Vessels or First Mobilization of the Tumor Followed by Clamping. nanUNKNOWN
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Study on Fluids Associated to Lung Cancer nanCOMPLETED
Identification of Biomarkers for Early Detection of Pancreatic Cancer nanCOMPLETED
Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix nanCOMPLETED
Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma nanNOT_YET_RECRUITING
Biomarker Breast Pap Test nanUNKNOWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China nanCOMPLETED
Markers for Early Detection of Prostate Cancer nanCOMPLETED
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants nanCOMPLETED
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer nanCOMPLETED
Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer nanCOMPLETED
Collection of Blood Specimens for Circulating Tumor Cell Analysis nanCOMPLETED
Prognostic Markers of Gynecologic Cancers nanCOMPLETED
Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications nanUNKNOWN
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma nanUNKNOWN
MicroRNA Markers in Head and Neck Cancers nanACTIVE_NOT_RECRUITING
Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation nanRECRUITING
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma nanCOMPLETED
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer nanCOMPLETED
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a SPECC1L binder may also engage these)

ProteinNameSimilarity
Q2KNA1 1.000 Q2KNA1 →
Q2KNA0 1.000 Q2KNA0 →
Q2KN97 1.000 Q2KN97 →
Q2KN98 1.000 Q2KN98 →
Q2KN99 1.000 Q2KN99 →
Q2KN95 0.999 Q2KN95 →
Q2KN96 0.999 Q2KN96 →
Q2KN94 0.997 Q2KN94 →
Q5M775 0.997 Q5M775 →
G5EEK3 0.995 G5EEK3 →
Q5SXY1 0.995 Q5SXY1 →
Q75EN7 0.995 Q75EN7 →
Q811D2 0.995 Q811D2 →
Q2KN93 0.995 Q2KN93 →
Q4KLT6 0.994 Q4KLT6 →
Q9ER69 0.994 Q9ER69 →
Q8SWR2 0.994 Q8SWR2 →
O08788 0.994 O08788 →
Q15007 0.994 Q15007 →
O15083 0.994 O15083 →
P13496 0.994 P13496 →
Q09350 0.994 Q09350 →
Q7YS99 0.993 Q7YS99 →
Q9XTT4 0.993 Q9XTT4 →
O62090 0.993 O62090 →
Q23529 0.993 Q23529 →
Q6P4K5 0.993 Q6P4K5 →
Q17353 0.993 Q17353 →
Q9LEZ4 0.993 Q9LEZ4 →
A1Z7Z9 0.993 A1Z7Z9 →